1-8 of 8
Sonja Zweegman
Close
Sort by
Journal Articles

Teclistamab impairs humoral immunity in patients with heavily pretreated myeloma: importance of immunoglobulin supplementation

Kristine A. Frerichs, Christie P. M. Verkleij, Maria Victoria Mateos, Thomas G. Martin, Cesar Rodriguez, Ajay Nooka, Arnob Banerjee, Katherine Chastain, Alfredo Perales-Puchalt, Tara Stephenson, Clarissa Uhlar, Rachel Kobos, Bronno van der Holt, Sandy Kruyswijk, Maria T. Kuipers, Kaz Groen, Deeksha Vishwamitra, Sheri Skerget, Diana Cortes-Selva, Margaret Doyle, Hans L. Zaaijer, Sonja Zweegman, Raluca I. Verona, Niels W. C. J. van de Donk
Journal: Blood Advances
Blood Adv (2023) 8 (1): 194–206.
https://doi.org/10.1182/bloodadvances.2023011658
Published: 2023
Includes: Supplemental data
Journal Articles

Real-world study of children and young adults with myeloproliferative neoplasms: identifying risks and unmet needs

Clinical Trials & Observations
Marta Sobas, Jean-Jacques Kiladjian, Yan Beauverd, Natalia Curto-Garcia, Parvis Sadjadian, Lee Yung Shih, Timothy Devos, Dorota Krochmalczyk, Serena Galli, Maria Bieniaszewska, Ilona Seferynska, Mary Frances McMullin, Anna Armatys, Adrianna Spalek, Joanna Waclaw, Mihnea Zdrenghea, Laurence Legros, François Girodon, Krzysztof Lewandowski, Anna Angona Figueras, Jan Samuelsson, Aitor Abuin Blanco, Pascale Cony-Makhoul, Angela Collins, Chloé James, Rajko Kusec, Marie Lauermannova, Maria Sol Noya, Malgorzata Skowronek, Lukasz Szukalski, Anna Szmigielska-Kaplon, Marielle Wondergem, Iryna Dudchenko, Joanna Gora Tybor, Kamel Laribi, Anna Kulikowska de Nalecz, Jean-Loup Demory, Katell Le Du, Sonja Zweegman, Carlos Besses Raebel, Radek Skoda, Stéphane Giraudier, Martin Griesshammer, Claire N. Harrison, Jean-Christophe Ianotto
Journal: Blood Advances
Blood Adv (2022) 6 (17): 5171–5183.
https://doi.org/10.1182/bloodadvances.2022007201
Published: 2022
Includes: Supplemental data
Journal Articles

Quantitative analysis of mRNA-1273 COVID-19 vaccination response in immunocompromised adult hematology patients

Clinical Trials & Observations
Sabine Haggenburg, Birgit I. Lissenberg-Witte, Rob S. van Binnendijk, Gerco den Hartog, Michel S. Bhoekhan, Nienke J. E. Haverkate, Dennis M. de Rooij, Johan van Meerloo, Jacqueline Cloos, Neeltje A. Kootstra, Dorine Wouters, Suzanne S. Weijers, Ester M. M. van Leeuwen, Hetty J. Bontkes, Saïda Tonouh-Aajoud, Mirjam H. M. Heemskerk, Rogier W. Sanders, Elianne Roelandse-Koop, Quincy Hofsink, Kazimierz Groen, Lucia Çetinel, Louis Schellekens, Yvonne M. den Hartog, Belle Toussaint, Iris M. J. Kant, Thecla Graas, Emma de Pater, Willem A. Dik, Marije D. Engel, Cheyenne R. N. Pierie, Suzanne R. Janssen, Edith van Dijkman, Meliawati Poniman, Judith A. Burger, Joey H. Bouhuijs, Gaby Smits, Nynke Y. Rots, Sonja Zweegman, Arnon P. Kater, Tom van Meerten, Pim G. N. J. Mutsaers, Jaap A. van Doesum, Annoek E. C. Broers, Marit J. van Gils, Abraham Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof
Journal: Blood Advances
Blood Adv (2022) 6 (5): 1537–1546.
https://doi.org/10.1182/bloodadvances.2021006917
Published: 2022
Includes: Supplemental data
Journal Articles

Efficacy and safety of daratumumab combined with all- trans retinoic acid in relapsed/refractory multiple myeloma

Clinical Trials & Observations
Kristine A. Frerichs, Monique C. Minnema, Mark-David Levin, Annemiek Broijl, Gerard M. J. Bos, Marie José Kersten, Tuna Mutis, Christie P. M. Verkleij, Inger S. Nijhof, Patricia W. C. Maas-Bosman, Saskia K. Klein, Sonja Zweegman, Pieter Sonneveld, Niels W. C. J. van de Donk
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5128–5139.
https://doi.org/10.1182/bloodadvances.2021005220
Published: 2021
Includes: Supplemental data
Journal Articles

Preclinical activity and determinants of response of the GPRC5DxCD3 bispecific antibody talquetamab in multiple myeloma

Christie P. M. Verkleij, Marloes E. C. Broekmans, Mark van Duin, Kristine A. Frerichs, Rowan Kuiper, A. Vera de Jonge, Martin Kaiser, Gareth Morgan, Amy Axel, Rengasamy Boominathan, Jocelyn Sendecki, Amy Wong, Raluca I. Verona, Pieter Sonneveld, Sonja Zweegman, Homer C. Adams, III, Tuna Mutis, Niels W. C. J. van de Donk
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2196–2215.
https://doi.org/10.1182/bloodadvances.2020003805
Published: 2021
Includes: Supplemental data
Journal Articles

Potent preclinical activity of HexaBody-DR5/DR5 in relapsed and/or refractory multiple myeloma

Hilma J. van der Horst, Anne T. Gelderloos, Martine E. D. Chamuleau, Esther C. W. Breij, Sonja Zweegman, Inger S. Nijhof, Marije B. Overdijk, Tuna Mutis
Journal: Blood Advances
Blood Adv (2021) 5 (8): 2165–2172.
https://doi.org/10.1182/bloodadvances.2020003731
Published: 2021
Includes: Supplemental data
Journal Articles

Prognostic and predictive performance of R-ISS with SKY92 in older patients with multiple myeloma: the HOVON-87/NMSG-18 trial

Clinical Trials & Observations
Rowan Kuiper, Sonja Zweegman, Mark van Duin, Martin H. van Vliet, Erik H. van Beers, Belinda Dumee, Michael Vermeulen, Jasper Koenders, Bronno van der Holt, Heleen Visser-Wisselaar, Markus Hansson, Annette W. G. van der Velden, H. Berna Beverloo, Marian Stevens-Kroef, Mark-David Levin, Annemiek Broijl, Anders Waage, Pieter Sonneveld
Journal: Blood Advances
Blood Adv (2020) 4 (24): 6298–6309.
https://doi.org/10.1182/bloodadvances.2020002838
Published: 2020
Includes: Supplemental data
Journal Articles

Treatment and relative survival in very elderly patients with DLBCL in The Netherlands: a population-based study, 1989 to 2015

Clinical Trials & Observations
Avinash G. Dinmohamed, Djamila E. Issa, Marjolein W. M. van der Poel, Harry C. Schouten, Pieternella J. Lugtenburg, Martine E. D. Chamuleau, Sonja Zweegman, Otto Visser
Journal: Blood Advances
Blood Adv (2017) 1 (21): 1839–1841.
https://doi.org/10.1182/bloodadvances.2017011031
Published: 2017
Includes: Supplemental data